Robert Thomas, MbChb, MRCP, MD, FRCR, discusses the results of the Pomi-T clinical trial. The study focused on the effects of Pomi-T on prostate-specific antigen (PSA) levels in prostate cancer patients. He highlights the main results, such as the reduction of PSA levels, and other important factors that should be considered when taking food supplements.
The use of supplements to complement a healthy and balanced diet for prostate cancer patients
11th December 2015
Oncology
Rate this content's potential impact on patient outcomes
Thank you!
Please share some more information on the rating you have given